List of Phenylephrine Hydrochloride drug patents
Phenylephrine Hydrochloride is owned by Paragon Bioteck.
Phenylephrine Hydrochloride contains Phenylephrine Hydrochloride.
Phenylephrine Hydrochloride has a total of 1 drug patent out of which 0 drug patents have expired.
Phenylephrine Hydrochloride was authorised for market use on 21 March, 2013.
Phenylephrine Hydrochloride is available in solution/drops;ophthalmic dosage forms.
Phenylephrine Hydrochloride can be used as dilation of the pupil.
The generics of Phenylephrine Hydrochloride are possible to be released after 14 November, 2033.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8859623 | PARAGON BIOTECK | Methods and compositions of stable phenylephrine formulations |
Nov, 2033
(10 years from now) | |
Drugs and Companies using PHENYLEPHRINE HYDROCHLORIDE ingredient
Market Authorisation Date: 21 March, 2013
Treatment: Dilation of the pupil
Dosage: SOLUTION/DROPS;OPHTHALMIC
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic